Esperion Therapeutics
ESPR
ESPR
155 hedge funds and large institutions have $805M invested in Esperion Therapeutics in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 54 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
8.04% less ownership
Funds ownership: 110.77% → 102.73% (-8%)
19% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 54
58% less call options, than puts
Call options by funds: $8.35M | Put options by funds: $19.9M
Holders
155
Holding in Top 10
1
Calls
$8.35M
Puts
$19.9M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$6.09M | |
| 3 | +$5.15M | |
| 4 |
Citigroup
New York
|
+$4.32M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.62M |
Top Sellers
| 1 | -$32.2M | |
| 2 | -$11.3M | |
| 3 | -$9.86M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$9.71M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$8.06M |